*Department of Environmental and Occupational Health, School of Public Health, CresP, Université de Montréal, Montreal, Quebec, Canada;
†CHU Poitiers, INSERM CIC1402, Université de Poitiers, CNRS 7267 EBI, Poitiers, France; and
‡Biology-Pharmacy-Public Health Department, CHU de Poitiers, Poitiers Cedex, France.
Correspondence: Nicolas Venisse, PhD, INSERM CIC1402, CHU Poitiers, 2 rue de la Milétrie, 86021 Poitiers Cedex, France (e-mail: [email protected]).
This research project was funded by the French National Research Program for Environmental and Occupational Health of Anses (2018/1/230).
The authors declare no conflict of interest.
Conception or design of the study: N. Plattard, R. Gnanasegaran, A. Krekesheva, N. Venisse, P. Carato, V. Migeot, and M. Albouy. Data collection: R. Gnanasegaran, N. Plattard, A. Krekesheva, and N. Venisse. Data analysis and interpretation: N. Plattard, R. Gnanasegaran, A. Krekesheva, and N. Venisse. Drafting the article: N. Plattard, R. Gnanasegaran, A. Krekesheva, and N. Venisse. Critical revision of the article: N. Venisse, S. Haddad, A. Dupuis, V. Migeot, P. Carato, and M. Albouy. Final approval of the version to be published: All authors.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.drug-monitoring.com).